|
Model Number TH-LX-M |
Device Problems
Difficult to Remove (1528); Difficult to Advance (2920)
|
Patient Problem
Vascular Dissection (3160)
|
Event Date 10/14/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Physician was attempting to use a turbohawk atherectomy device to treat a lesion.Lesion stenosis was 99%.Device was inspected with no issues noted.A non-medtronic guidewire was used.Device prepped per ifu, with no issues noted.It was reported that patient had acute bifurcation, physician had trouble initially getting sheath up and over.Once sheath was in place the lesion was in the mid superficial femoral artery (sfa), very tight and highly calcified lesion, the physician did pre-dilation with a 7mm non-medtronic balloon, before inserting the turbohawk.Physician made 4-5 passes.When removing the turbohawk from sheath physician met resistance.When the turbohawk was removed it was noted that there was a possible wire prolapse.No intervention was required for the removal of the device.The device was removed from the patient; however, it was noted there was iliac dissection in the patient.The physician stated that the dissection happened when the device was pulled back into the sheath.2 stents were placed in the right iliac to complete the procedure.No patient injury reported.
|
|
Manufacturer Narrative
|
Product analysis: the device returned coiled inside 4 biohazard bags.Device was decontaminated with cidex opa solution soak and tergazyme soak.The device was returned with the guidewire lumen detached from the tip but still attached to the bent guidewire.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|